PolyMedix Inc. Presents Anti-tuberculosis Data at 5th European Conference on Clinical and Social Research on AIDS and Drugs
RADNOR, Pa.--(BUSINESS WIRE)--PolyMedix, Inc. (OTC BB: PYMX, www.polymedix.com), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders based on biomimetics, is making a poster presentation this week at the 5th European Conference on Clinical and Social Research on AIDS and Drugs, Vilnius, Lithuania April 28-30, 2009.